Pellegrino Joseph P JR 4
4 · LEMAITRE VASCULAR INC · Filed Mar 30, 2026
Research Summary
AI-generated summary of this filing
Lemaitre Vascular (LMAT) Director Joseph Pellegrino Receives Award
What Happened
- Joseph P. Pellegrino Jr., a director of Lemaitre Vascular (LMAT), was credited with a total of 16.2 shares on March 26, 2026. These were reported as derivative acquisitions (code A) at $0.00 each — dividend equivalent rights that accrued on previously granted restricted stock units (RSUs) and performance share units (PSUs). No cash purchase or open-market trade occurred.
Key Details
- Transaction date: 2026-03-26; Form 4 filed: 2026-03-30 (filed within the usual 2-business-day Form 4 deadline for a 3/26 transaction).
- Shares acquired: seven separate accruals totaling 16.2 shares; price reported: $0.00 per share; reported value: $0.
- Nature of award: dividend-equivalent rights that are the economic equivalent of one share each and vest proportionately with the underlying RSU/PSU awards.
- Grants tied to underlying awards dated: 12/12/2022, 12/8/2023, 12/6/2024, and 12/10/2025 (per footnotes F1–F7).
- Shares owned after the transaction: not specified in the provided excerpt of the filing.
Context
- These are not purchases or sales — they are accruals of dividend-equivalent units associated with existing equity awards. Such credits typically increase the insider’s eventual share delivery when the underlying RSUs/PSUs vest and do not by themselves indicate a buy/sell signal.
Insider Transaction Report
Form 4
Pellegrino Joseph P JR
Director
Transactions
- Award
Dividend Equivalent Rights
[F1]2026-03-26+1.544→ 21.518 total→ Common Stock (1.544 underlying) - Award
Dividend Equivalent Rights
[F2]2026-03-26+1.544→ 20.835 total→ Common Stock (1.544 underlying) - Award
Dividend Equivalent Rights
[F3]2026-03-26+2.637→ 23.591 total→ Common Stock (2.637 underlying) - Award
Dividend Equivalent Rights
[F4]2026-03-26+3.16→ 24.295 total→ Common Stock (3.16 underlying) - Award
Dividend Equivalent Rights
[F5]2026-03-26+2.863→ 15.346 total→ Common Stock (2.863 underlying) - Award
Dividend Equivalent Rights
[F6]2026-03-26+3.244→ 14.727 total→ Common Stock (3.244 underlying) - Award
Dividend Equivalent Rights
[F7]2026-03-26+1.208→ 1.208 total→ Common Stock (1.208 underlying)
Footnotes (7)
- [F1]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- [F2]These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- [F3]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- [F4]These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- [F5]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- [F6]These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- [F7]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Signature
/s/ Laurie A. Churchill, Attorney-in-fact|2026-03-30